Piper Jaffray believes the subpoena Wright Medical disclosed yesterday is likely to be immaterial to the company and recommends using the weakness in shares as a buying opportunity. Piper said it would be an aggressive buyer of the stock at current levels and maintains a $24 price target for shares.
America has no tolerance for wealthy people griping about their financial woes. But they have concerns too.